Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.6568
-0.0192 (-2.84%)
At close: Jan 16, 2026, 4:00 PM EST
0.6579
+0.0011 (0.17%)
After-hours: Jan 16, 2026, 7:20 PM EST
Rallybio Market Cap
Rallybio has a market cap or net worth of $27.75 million as of January 16, 2026. Its market cap has decreased by -30.34% in one year.
Market Cap
27.75M
Enterprise Value
-31.38M
1-Year Change
-30.34%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $27.75M, a decrease of -93.16%. That is a compound annual growth rate of -45.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 27.75M | -4.27% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |